Understanding and Helping Families: Parents With Psychosis
- Conditions
- PsychosisSchizophreniaParenting
- Interventions
- Behavioral: Triple P Positive Parenting Programme
- Registration Number
- NCT02622048
- Lead Sponsor
- University of Manchester
- Brief Summary
The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.
- Detailed Description
The trial will be split into two stages.
Stage 1: Parents with no history of serious mental health problems and parents who have a history of psychosis or schizophrenia, who have children aged 3-10 years old, will take part in the Revised Five Minute Speech Sample (FMSS) and the Modified Camberwell Family Interview (CFI). They will also complete various measures looking at parental well-being, depression, anxiety and stress as well as parenting behaviours and interpretations of their child behaviour. In addition the PANSS interview will also be used. These interviews will be coded to investigate attributional patterns.
Stage 2: Parents who are experiencing psychosis, who took part in stage 1 will proceed to stage 2 if they want to. Parents will be seen weekly and take part in a guided self-help parenting intervention. This will require weekly visits over 10 weeks to the parents. During this time, symptoms, mood, general well-being and parenting behaviours will be monitored.
There will be no randomisation: all parents experiencing psychosis will receive the intervention.
Children do not attend the sessions, but it is hoped that parents practice the skills learned.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Stage 2 Parents experiencing psychosis Triple P Positive Parenting Programme Parents all receive the self-directed Triple P Positive Parenting Programme
- Primary Outcome Measures
Name Time Method Positive and Negative Syndrome Scale (PANSS) Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression
Five Minute Speech Sample (FMSS) Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Assessment of Expressed Emotion using a 5 minute uninterrupted interview
Modified Camberwell Family Interview (CFI) Initial Ax only In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children.
- Secondary Outcome Measures
Name Time Method Depression, Anxiety and Stress Scale (DASS-21) Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Self-reported depression, anxiety and stress using a short form scale
Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Self-reported general well-being
Parenting and Family Adjustment Scale (PAFAS) Baseline, 1, 5, 10, follow up An assessment of parenting skills and family relationships.
Eyberg Child Behaviour Inventory (ECBI) Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Parents self-reported child problem behaviour
Strengths and Difficulties Questionnaire (SDQ) Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention.
Trial Locations
- Locations (1)
The University of Manchester
🇬🇧Manchester, Lancashire, United Kingdom